267 related articles for article (PubMed ID: 34941687)
1. Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism.
Wang Z; Han H; Wang C; Zheng Q; Chen H; Zhang X; Hou R
Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941687
[TBL] [Abstract][Full Text] [Related]
2. Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis.
Wang W; Yang X; Chen Y; Ye X; Jiang K; Xiong A; Yang L; Wang Z
J Appl Toxicol; 2020 Nov; 40(11):1534-1544. PubMed ID: 32618019
[TBL] [Abstract][Full Text] [Related]
3. Combined Hepatotoxicity and Toxicity Mechanism of Intermedine and Lycopsamine.
Wang Z; Qiao L; Zheng Q; Han H; Li Z; Zhang X; Chen H
Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136571
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
Yang M; Ruan J; Fu PP; Lin G
Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolizidine alkaloids enhance alcohol-induced hepatocytotoxicity in vitro in normal human hepatocytes.
Neuman MG; Cohen LB; Steenkamp V
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):53-68. PubMed ID: 28379594
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update.
Teschke R; Vongdala N; Quan NV; Quy TN; Xuan TD
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638760
[TBL] [Abstract][Full Text] [Related]
7. Development of an in vitro screening method of acute cytotoxicity of the pyrrolizidine alkaloid lasiocarpine in human and rodent hepatic cell lines by increasing susceptibility.
Forsch K; Schöning V; Disch L; Siewert B; Unger M; Drewe J
J Ethnopharmacol; 2018 May; 217():134-139. PubMed ID: 29454024
[TBL] [Abstract][Full Text] [Related]
8. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
[TBL] [Abstract][Full Text] [Related]
9. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.
Yang M; Ma J; Ruan J; Ye Y; Fu PP; Lin G
Arch Toxicol; 2019 Aug; 93(8):2197-2209. PubMed ID: 31222523
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice.
Yang X; Wang H; Ni HM; Xiong A; Wang Z; Sesaki H; Ding WX; Yang L
Redox Biol; 2017 Aug; 12():264-273. PubMed ID: 28282614
[TBL] [Abstract][Full Text] [Related]
11. Assessment of pyrrolizidine alkaloid-induced toxicity in an in vitro screening model.
Li YH; Kan WL; Li N; Lin G
J Ethnopharmacol; 2013 Nov; 150(2):560-7. PubMed ID: 24045176
[TBL] [Abstract][Full Text] [Related]
12. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure.
Waizenegger J; Braeuning A; Templin M; Lampen A; Hessel-Pras S
Food Chem Toxicol; 2018 Apr; 114():215-226. PubMed ID: 29458164
[TBL] [Abstract][Full Text] [Related]
13. Regulatory role of oxidative stress in retrorsine - Induced apoptosis and autophagy in primary rat hepatocytes.
Zhu Y; Zhang S; Shao Y; Tang L; Zhang C; Tang S; Lu H
Ecotoxicol Environ Saf; 2024 Jul; 279():116515. PubMed ID: 38810283
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.
Ma J; Li M; Li N; Chan WY; Lin G
Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolizidine Alkaloids Induce Cell Death in Human HepaRG Cells in a Structure-Dependent Manner.
Glück J; Waizenegger J; Braeuning A; Hessel-Pras S
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379168
[TBL] [Abstract][Full Text] [Related]
16. The toxicokinetic and metabolism of structurally diverse pyrrolizidine alkaloids in rats.
To YC; Pan Y; Yan X; He Y; Lin G
J Ethnopharmacol; 2024 Mar; 321():117390. PubMed ID: 37956911
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Bcl-xL degradation and mitochondrial-mediated apoptotic pathway in pyrrolizidine alkaloids-induced apoptosis in hepatocytes.
Ji L; Chen Y; Liu T; Wang Z
Toxicol Appl Pharmacol; 2008 Sep; 231(3):393-400. PubMed ID: 18586292
[TBL] [Abstract][Full Text] [Related]
18. Protective mechanisms of N-acetyl-cysteine against pyrrolizidine alkaloid clivorine-induced hepatotoxicity.
Ji L; Liu T; Chen Y; Wang Z
J Cell Biochem; 2009 Oct; 108(2):424-32. PubMed ID: 19623661
[TBL] [Abstract][Full Text] [Related]
19. Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides.
Moore DJ; Batts KP; Zalkow LL; Fortune GT; Powis G
Toxicol Appl Pharmacol; 1989 Nov; 101(2):271-84. PubMed ID: 2815083
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.
Liu W; Li X; Zhou B; Fang S; Ho W; Chen H; Liang H; Ye L; Tang J
PLoS One; 2017; 12(6):e0179379. PubMed ID: 28650983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
